| 상품명칭 |
Drotaverine |
| 영문 이름 |
Drotaverine; (1Z)-1-(3,4-diethoxybenzylidene)-6,7-diethoxy-1,2,3,4-tetrahydroisoquinolinato(4-); (1Z)-1-(3,4-Diethoxybenzylidene)-6,7-diethoxy-1,2,3,4-tetrahydroisoquinoline; 1-(3,4-Diethoxybenzylidene)-6,7diethoxy-1,2,3,4-tetrahydroisoquinoline; 1-[(3,4-Diethoxyphenyl)methylene]-6,7-diethoxy-1,2,3,4-tetrahydroisoquinoline; 14009-24-6; DRA; drotaverin; isoquinoline, 1-[(3,4-diethoxyphenyl)methylene]-6,7-diethoxy-1,2,3,4-tetrahydro-, (1Z)-; Tetraspasmin-Lefa; (1Z)-1-[(3,4-diethoxyphenyl)methylidene]-6,7-diethoxy-1,2,3,4-tetrahydroisoquinoline hydrochloride; Drotaverin Hydrochloride |
| 분자식 |
C24H32ClNO4 |
| 분자량 |
433.9682 |
| InChI |
InChI=1/C24H31NO4.ClH/c1-5-26-21-10-9-17(14-22(21)27-6-2)13-20-19-16-24(29-8-4)23(28-7-3)15-18(19)11-12-25-20;/h9-10,13-16,25H,5-8,11-12H2,1-4H3;1H/b20-13-; |
| cas번호 |
14009-24-6 |
| 분자 구조 |
|
| 비등점 |
564°C at 760 mmHg |
| 인화점 |
240.7°C |
| 증기압 |
9.61E-13mmHg at 25°C |
| 위험성 표시 |
|
| 리스크 규칙 |
|
| 보안 규칙 |
|
|
